<DOC>
	<DOCNO>NCT00411255</DOCNO>
	<brief_summary>This research study examine whether magnetic electrical stimulation brain improve involuntary closure eyelids patient blepharospasm Meige syndrome ; condition belong group neurological disorder call dystonias . Blepharospasm Meige syndrome cause excessive involuntary closure eyelid blink . In early study patient writer 's cramp , another form dystonia , symptom improve temporarily brain stimulation . Interested people 18 year age old blepharospasm Meige syndrome may eligible study . Candidates screen medical history , physical examination blink reflex test . Participants undergo brain stimulation evaluation stimulation test response , follow : Procedures - Transcranial magnetic stimulation ( TMS ) : A wire coil hold patient 's scalp . A brief electrical current pass coil , create magnetic pulse stimulate brain . The subject hears click may feel pull sensation skin coil . There may twitch muscle face , arm leg . The subject may ask tense certain muscle slightly perform simple action . The effect TMS muscle detect small metal disk electrode tap skin arm leg . TMS do eight ten test day . - Repetitive TMS ( rTMS ) : The procedure TMS , except repeat magnetic pulse deliver short burst . RTMS do eight ten test day . - Theta burst stimulation ( TBS ) : A form rTMS involve short burst impulse . TBS do four study day . - Cathodal transcranial DC stimulation ( tDCS ) : Two conductive-rubber electrode place saline-soaked sponge position two area head . A constant weak electrical current flow apply 20 minute . tDCS do two study day . Evaluations - Physician observation : The subject 's eye videotape 5 minute TMS session . A physician count many time subject blink 5 minute . - Questionnaire : Subjects ask rate symptom brain stimulation . - Electrophysiological test blink reflex : Wires tap skin nose temple record eye movement blinking . A thin plastic rod place skin right e ...</brief_summary>
	<brief_title>Brain Stimulation Treat Blepharospasm Meige Syndrome</brief_title>
	<detailed_description>BACKGROUND : Blepharospasm ( BSP ) common form focal dystonia , etiology underlie pathophysiological mechanism still obscure . BSP characterize excessive involuntary closure eyelid . Pathological change excitability primary motor cortex ( MC ) secondary motor area , anterior cingulate ( AC ) , pre-and supplementary cortex ( PMC , SMA ) suggest electrophysiological brain imaging study . It conceivable modulation excitability area may lead amelioration symptom BSP . Cortical excitability experimentally change various well-established electrophysiological technique non-invasively . METHODS : In pilot protocol , study 30 patient BSP , use repetitive transcranial magnetic stimulation ( rTMS ) AC , PMC , SMA MC two different inhibitory mode : low frequency rTMS ( ( lf ) rTMS ) continuous theta burst stimulation cTBS . Furthermore , apply transcranial direct stimulation ( tDCS ) inhibitory mode ( cathodal tDCS ) MC low intensity high frequency supraorbital electrical stimulation ; latter perform patient 7 healthy subject . The effect blepharospasm objectively measure electrophysiological measure ( blink reflex recovery curve ( BRR ) , blink rate observation investigator blind intervention , subjective rating patient . OBJECTIVES : We hypothesize find variable amount clinical improvement BSP patient different method . With study , aim get insight underlie pathophysiological mechanism BSP identify method non-invasive brain stimulation may clinically efficacious .</detailed_description>
	<mesh_term>Dystonia</mesh_term>
	<mesh_term>Dystonic Disorders</mesh_term>
	<mesh_term>Blepharospasm</mesh_term>
	<criteria>INCLUSION CRITERIA PATIENTS : Patients idiopathic BSP MeigeSyndrome ( =BSP plus oromandibular dystonia ) . Age 18 year old . Normal finding medical history , physical neurological examination , except dystonia ( case patient H &amp; P NIH within last 12 month ; undergo exam first study day ) . Last treatment botulinum toxin three month ago . INCLUSION CRITERIA CONTROLS : Age 18 year old Normal finding medical history , physical neurological examination No history neuroleptic medications/ prior use neuroleptic ( Haldol ( Registered Trademark ) ) Not treat take antidepressant , antiseizure medication , anticholinergic drug ( Artane ( Registered Trademark ) ) muscle relaxant within past 4 week EXCLUSION CRITERIA PATIENTS : Any following exclude patient study : Other disease involuntary blinking ( Hemifacial spasm , Tic disorder , Tardive Dyskinesia , Tardive dystonia , etc ) . BSP normal recovery R2 BRR . Participation clinical trial 2 week precede study . History seizure disorder . Pregnancy pregnancy test perform woman childbearing potential . Symptoms clinically relevant illness 4 week first study day , include history neurological disorder condition require use antidepressant , neuroleptic medication antiseizure meds. , anticholinergic drug muscle relaxant . History neuroleptic medications/prior use neuroleptic . EXCLUSION CRITERIA CONTROLS : A botulinum toxin injection within 3 month start protocol Any condition require use antidepressant , antipsychotic antiseizure medication Can follow instruction entire record Not able provide consent participate study Patients screen recruited outpatient clinic HMCS , NINDS . Age match volunteer recruit NIH Patient Recruitment Public Liaison Office .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 19, 2010</verification_date>
	<keyword>Blink Reflex</keyword>
	<keyword>Transcranial Magnetic Stimulation ( TMS )</keyword>
	<keyword>Dystonia</keyword>
	<keyword>Blepharospasm</keyword>
	<keyword>BSP</keyword>
	<keyword>Focal Dystonia</keyword>
</DOC>